Zioptan: payments to doctors
Payments that named Zioptan as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $284K
- Providers
- 908
- Transactions
- 1,887
- Average per transaction
- $151
The per-transaction average — $151 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 908 providers the average total is $313, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Akorn, Inc. | $266,748 | 93.8% |
| Akorn Operating Company LLC | $17,633 | 6.2% |